ADJUVANT CAPECITABINE: A NEW STANDARD OF CARE IN BILIARY TRACT CANCER

被引:3
|
作者
Lamarca, Angela [1 ]
Gambardella, Valentina [2 ]
Cejalvo, Juan-Miguel [2 ]
Fleitas-Kanonnikoff, Tania [2 ]
Cervantes, Andres [2 ]
机构
[1] Univ Manchester, Div Canc Sci, Dept Med Oncol, Manchester, Lancs, England
[2] Univ Valencia, Biomed Res Inst INCLIVA, Dept Med Oncol, CiberOnc, Valencia, Spain
关键词
GEMCITABINE; CHOLANGIOCARCINOMA; CHEMOTHERAPY; THERAPY;
D O I
10.1136/esmoopen-2019-000547
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer
    Goetze, Thorsten Oliver
    Kochen, Lisa
    Vortmeyer, Doerthe
    Al-Batran, Salah-Eddin
    Habibzada, Timorshah
    Brunner, Marius
    Ettrich, Thomas Jens
    Gonzalez-Carmona, Maria A.
    Kohne, Claus-Henning
    Modest, Dominik Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [12] REAL WORLD COMPARISON BETWEEN CAPECITABINE AND 5-FLUOROURACIL AS ADJUVANT THERAPY IN BILIARY TRACT CANCER
    Heo, Jun
    Jung, Min Kyu
    Kwon, Hyung Jun
    Cho, Chang Min
    Lee, Dong Wook
    Lee, Yong Woo
    Lee, Jun Hyup
    Kim, Sung Bum
    GASTROENTEROLOGY, 2024, 166 (05) : S1051 - S1052
  • [13] ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer.
    Goetze, Thorsten
    Eickhoff, Regina
    Pons, Miriam
    Kochen, Lisa
    Vortmeyer, Doerthe
    Al-Batran, Salah-Eddin
    Habibzade, Timursah
    Adler, Marius
    Gonzalez-Carmona, Maria A.
    Ettrich, Thomas Jens
    Koehne, Claus-Henning
    Pink, Daniel
    van Boemmel, Florian
    Pession, Ursula
    Wehler, Thomas
    Modest, Dominik Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS583 - TPS583
  • [14] Adjuvant Nivolumab in Esophageal Cancer - A New Standard of Care
    Ilson, David H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1269 - 1271
  • [15] Adjuvant chemotherapy for lung cancer - A new standard of care
    Blum, RH
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04): : 404 - 405
  • [16] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    Primrose, John N.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2127 - 2129
  • [17] Postoperative adjuvant treatments for biliary tract cancer
    Furuse, Junji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (05): : 463 - 467
  • [18] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    John N. Primrose
    Annals of Surgical Oncology, 2020, 27 : 2127 - 2129
  • [19] BILCAP-study: Should patients with resected biliary tract cancer really receive adjuvant chemotherapy with capecitabine?
    Manzini, G.
    Klotz, U.
    Hines, I.
    Henne-Bruns, D.
    Kremer, M.
    Kirchner, M.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [20] TOPAZ-1: a new standard of care for advanced biliary tract cancers?
    Ebia, Matthew, I
    Sankar, Kamya
    Osipov, Arsen
    Hendifar, Andrew E.
    Gong, Jun
    IMMUNOTHERAPY, 2023, 15 (07) : 473 - 476